Reporting person on SEC Form 4

Mary E. Klotman

Mary E. Klotman is Director at Amgen. OQRO lists 1 transaction filed with the SEC under this name, the latest on May 21, 2026, each linked to the official Form 4.

Director

Disclosures on record

1

Companies involved

1

Disclosure history

AmgenAMGN
May 19, 2026665disclosed May 21
Details Official record